Skip to main content
. 2016 Aug 24;7(39):64043–64052. doi: 10.18632/oncotarget.11581

Table 2. Association between methylation difference (%) and clinicopathological parameters.

Parameters NO. Normal Tumor ΔMean P
Gender 0.66
 Male 111 61.4 65.7 4.3
 Female 10 70.6 72.7 2.1
Age 0.53
 <58 52 61.6 66.8 5.2
 ≥58 69 62.6 66.0 3.4
Alcohol habit 0.43
 No 99 59.8 65.1 5.3
 Yes 86 65.1 67.9 2.8
Smoking 0.05
 No 41 59.1 67.4 8.3
 Yes 80 63.7 65.8 2.1
Nerve invasion 0.63
 No 95 62.4 66.9 4.5
 Yes 26 61.2 64.2 3.0
Vessels invasion 0.86
 No 102 62.5 66.5 4.0
 Yes 19 60.4 65.5 5.1
T stage 0.88
 T1-2 27 59.1 63.0 3.9
 T3 94 63.0 67.3 4.3
N stage
 N0 57 57.6 65.1 7.5 0.04
 N1-3 64 66.1 67.5 1.4
TNM stage 0.13
 I-II 61 58.6 65.1 6.5
 III 60 65.7 67.6 1.9
Differentiation 0.46
 Well 13 65.8 64.9 −0.9
 Moderate 68 61.1 66.5 5.4
 Poor 40 62.7 66.6 3.9
Lesion location 0.15
 Upper thoracic 44 61.7 67.9 6.2
 Middle thoracic 46 63.6 64.1 0.5
 Low thoracic 31 60.5 67.4 6.9